Biological Variations of Lupus Anticoagulant, Antithrombin, Protein C, Protein S, and von Willebrand Factor Assays

Weiling Shou; Qian Chen; Wei Wu; Wei Cui

doi:10.1055/s-0035-1552588

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2016; 42(01): 087-092
DOI: 10.1055/s-0035-1552588

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Biological Variations of Lupus Anticoagulant, Antithrombin, Protein C, Protein S, and von Willebrand Factor Assays

Weiling Shou

¹Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

,

Qian Chen

¹Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

,

Wei Wu

¹Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

,

Wei Cui

¹Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

› Author Affiliations

Abstract

The results of lupus anticoagulant (LA), antithrombin (AT), protein C (PC), and protein S (PS) testing, and the values of von Willebrand factor antigen (VWF:Ag) are important in diagnosis and therapeutic monitoring of thrombosis and hemostasis diseases. Till now, no published study has focused on the biological variations in LA testing, and only a few studies have examined the biological variations of AT, PC, PS, and VWF:Ag. With the latest fully automated instruments and improved reagents, the analytical, within-subject, and between-subject biological variations were estimated for these five coagulant parameters in a cohort of 25 apparently healthy subjects. Blood specimens were collected at 8:00 am, 12:00 pm, and 4:00 pm on days 1, 3, and 5. The analytical biological variation (CV_A) values of all the parameters were less than 3%. The within-subject biological variation (CV_W) and between-subject biological variation (CV_G) values of the LA normalized ratio were 4.64 and 6.83%, respectively. No significant differences were observed in the intraday and interday biological variations of LA tests, or in AT, PC, PS, and VWF:Ag values. Additionally, the utility of the conventional population-based reference intervals of the five coagulation parameters was evaluated by the index of individuality, and data on CV_W and CV_A were used to calculate the reference change value to identify the significance of changes in serial results from the same individual.

Keywords

biological variation - thrombosis and hemostasis tests - lupus anticoagulant - index of individuality - reference change value

Full Text

References

References
1 Plebani M, Favaloro EJ, Lippi G. Patient safety and quality in laboratory and hemostasis testing: a renewed loop?. Semin Thromb Hemost 2012; 38 (6) 553-558
2 Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27 (5) 409-437
3 Minchinela J, Ricós C, Perich C , et al. Biological variation database, and quality specifications for imprecision, bias and total error (desirable and minimum). The 2014 update. Available at: http://www.westgard.com/biodatabase-2014-update.htm . Accessed: November 14, 2014
4 Costongs GM, Bas BM, Janson PC, Hermans J, Brombacher PJ, van Wersch JW. Short-term and long-term intra-individual variations and critical differences of coagulation parameters. J Clin Chem Clin Biochem 1985; 23 (7) 405-410
5 Chambless LE, McMahon R, Wu K, Folsom A, Finch A, Shen YL. Short-term intraindividual variability in hemostasis factors. The ARIC study. Atherosclerosis risk in communities intraindividual variability study. Ann Epidemiol 1992; 2 (5) 723-733
6 Melzi d'Eril G, Anesi A, Rizzo V , et al. Biological variation in Protein C, Protein S, and Antithrombin concentrations in plasma of healthy subjects. Eur J Clin Chem Clin Biochem 1997; 35 (4) 257-260
7 Wada Y, Kurihara M, Toyofuku M , et al. Analytical goals for coagulation tests based on biological variation. Clin Chem Lab Med 2004; 42 (1) 79-83
8 Kilercik M, Coskun A, Serteser M, Inan D, Unsal I. Biological variations of ADAMTS13 and von Willebrand factor in human adults. Biochem Med (Zagreb) 2014; 24 (1) 138-145
9 Banfi G, Del Fabbro M. Biological variation in tests of hemostasis. Semin Thromb Hemost 2009; 35 (1) 119-126
10 Chen Q, Shou W, Wu W , et al. Biological and analytical variations of 16 parameters related to coagulation screening tests and the activity of coagulation factors. Semin Thromb Hemost 2015; 41 (3) 336-341
11 Tripodi A. Laboratory testing for lupus anticoagulants: a review of issues affecting results. Clin Chem 2007; 53 (9) 1629-1635
12 Baglin T, Gray E, Greaves M , et al; British Committee for Standards in Haematology. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 2010; 149 (2) 209-220
13 Favaloro EJ, Bodó I, Israels SJ, Brown SA. von Willebrand disease and platelet disorders. Haemophilia 2014; 20 (Suppl. 04) 59-64
14 Fraser CG. Biological Variation: From Principles to Practice. Washington DC: AACC Press; 2001
15 Perich C, Minchinela J, Ricós C , et al. Biological variation database: structure and criteria used for generation and update. Clin Chem Lab Med 2015; 53 (2) 299-305
16 Plebani M, Padoan A, Lippi G. Biological variation: back to basics. Clin Chem Lab Med 2015; 53 (2) 155-156
17 Lippi G, Favaloro EJ, Franchini M. Dangers in the practice of defensive medicine in hemostasis testing for investigation of bleeding or thrombosis: part I—routine coagulation testing. Semin Thromb Hemost 2014; 40 (7) 812-824
18 CLSI. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline. CLSI Document H21-A5, 5th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2010
19 Pengo V, Tripodi A, Reber G , et al; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009; 7 (10) 1737-1740
20 CLSI. Laboratory Testing for the Lupus Anticoagulant; Approved Guideline. CLSI document H60-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2014
21 Van Hoydonck PG, Schouten EG, Temme EH. Reproducibility of blood markers of oxidative status and endothelial function in healthy individuals. Clin Chem 2003; 49 (6 Pt 1) 963-965
22 Sousa NC, Anicchino-Bizzacchi JM, Locatelli MF, Castro V, Barjas-Castro ML. The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor. Haematologica 2007; 92 (2) 236-239
23 Favaloro EJ. Diagnosing von Willebrand disease: a short history of laboratory milestones and innovations, plus current status, challenges, and solutions. Semin Thromb Hemost 2014; 40 (5) 551-570
24 Porta M, Maneschi F, White MC, Kohner EM. Twenty-four hour variations of von Willebrand factor and factor VIII-related antigen in diabetic retinopathy. Metabolism 1981; 30 (7) 695-699
25 Timm A, Fahrenkrug J, Jørgensen HL, Sennels HP, Goetze JP. Diurnal variation of von Willebrand factor in plasma: the Bispebjerg study of diurnal variations. Eur J Haematol 2014; 93 (1) 48-53
26 Favaloro EJ, Bonar RA, Meiring M , et al. Evaluating errors in the laboratory identification of von Willebrand disease in the real world. Thromb Res 2014; 134 (2) 393-403
27 Petersen PH, Fraser CG, Sandberg S, Goldschmidt H. The index of individuality is often a misinterpreted quantity characteristic. Clin Chem Lab Med 1999; 37 (6) 655-661
28 Ricós C, Cava F, García-Lario JV , et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004; 64 (3) 175-184
29 Trapé J, Botargues JM, Porta F , et al. Reference change value for alpha-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease. Clin Chem 2003; 49 (7) 1209-1211
30 Sambasivan AS, Lepage N, Filler G. Cystatin C intrapatient variability in children with chronic kidney disease is less than serum creatinine. Clin Chem 2005; 51 (11) 2215-2216
31 Biosca C, Ricós C, Lauzurica R, Petersen PH. Biological variation at long-term renal post-transplantation. Clin Chim Acta 2006; 368 (1–2) 188-191
32 Ricós C, Iglesias N, García-Lario JV , et al. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007; 44 (Pt 4): 343-352
33 Montagnana M, Salvagno GL, Lippi G. Circadian variation within hemostasis: an underrecognized link between biology and disease?. Semin Thromb Hemost 2009; 35 (1) 23-33